GlassScriptPhysician profile
Rogin Subedi
NPI 1154797991
$24,296.36
in general payments reported to CMS, 2019-2025
33 companies · $1,651 in 2025
The $1,651 reported for 2025 was more than what 80% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $32.93 · 2020: $331 · 2021: $3,792 · 2022: $6,174 · 2023: $4,728 · 2024: $7,587 · 2025: $1,651.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $8,017 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $3,100 · Travel and Lodging: $2,848.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $8,017.26 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $3,100.00 |
| Travel and Lodging | $2,848.24 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $8,292.09 | 2021-2025 | Micra, Corevalve Evolut R, Selectsecure |
| Inari Medical, INC. | $5,013.19 | 2021-2025 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Boston Scientific Corporation | $4,146.13 | 2019-2024 | Versacross Access Solution, Avvigo Guidance System |
| Angiodynamics, INC. | $1,661.07 | 2022-2024 | Alphavac |
| Abbott Laboratories | $1,579.62 | 2019-2025 | Supera, Esprit, Cardiomems |
| Abiomed | $484.15 | 2023-2025 | Impella |
| Amgen INC. | $363.66 | 2021-2025 | Repatha, Repatha |
| Shockwave Medical, INC | $359.39 | 2022-2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| E.R. Squibb & Sons, L.L.C. | $241.99 | 2021-2025 | Camzyos |
| Astrazeneca Pharmaceuticals LP | $227.60 | 2021 | |
| Bard Peripheral Vascular, INC. | $202.65 | 2025 | Rotarexs 6 F X 135 Cm |
| Stryker Corporation | $196.28 | 2025 | Ct Thrombectomy System Kit, Flowtriever Catheter, S, Flowtriever |
| Livanova USA, INC. | $175.76 | 2023 | Tandemlife |
| Penumbra, INC. | $154.54 | 2024-2025 | Indigo System, Penumbra System |
| Cardiovascular Systems INC. | $139.18 | 2021-2022 |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $136.31 | 2024 | |
| Siemens Medical Solutions USA, INC. | $112.28 | 2022 | |
| Pfizer INC. | $111.97 | 2023-2025 | |
| Sanofi-Aventis U.S. LLC | $99.61 | 2023-2024 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $98.01 | 2023-2025 | Lifevest |
| Merck Sharp & Dohme LLC | $93.26 | 2023-2025 | Verquvo |
| W. L. Gore & Associates, INC. | $83.88 | 2024-2025 | Gore Viabahn Vbx Balloon Expandable Endo |
| Novartis Pharmaceuticals Corporation | $52.34 | 2024-2025 | |
| Kiniksa Pharmaceuticals International, Plc | $47.11 | 2024 | Arcalyst |
| Imperative Care, INC | $44.33 | 2024-2025 | Symphony Catheter |
| Philips North America LLC | $41.34 | 2025 | Technical Education Mri, Pioneer |
| Baxter Healthcare | $36.36 | 2025 | Hillrom - Carnation Ambulatory Monitor |
| Astellas Pharma US INC | $22.97 | 2022 | |
| Cardiva Medical, INC. | $20.89 | 2023 | Cardiva Vascade 6/7f Vcs |
| Cvrx, INC. | $15.39 | 2025 | Barostim Neo System |
| Janssen Pharmaceuticals, INC | $15.05 | 2024 | Xarelto |
| Boehringer Ingelheim Pharmaceuticals, INC. | $14.86 | 2024 | Jardiance |
| Azurity Pharmaceuticals, INC. | $13.10 | 2024 | Edarbi |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rogin Subedi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.